6.35
price up icon0.32%   0.02
after-market Handel nachbörslich: 6.35
loading

Finanzdaten der Organon Co-Aktie (OGN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
5.93%
1,507.00
1,602.00 1,594.00 1,513.00 1,592.00
Cost Of Revenue
2.82%
766.00
745.00 720.00 672.00 696.00
Gross Profit
13.54%
741.00
857.00 874.00 841.00 896.00
Operating Expenses
44.79%
889.00
614.00 645.00 740.00 767.00
Interest Income/Expense
5.47%
121.00
128.00 131.00 124.00 132.00
Benefits Costs and Expenses
21.78%
1,655.00
1,359.00 1,365.00 1,412.00 1,463.00
Costs And Expenses
21.78%
1,655.00
1,359.00 1,365.00 1,412.00 1,463.00
Operating Income/Loss
160.91%
-148.00
243.00 229.00 101.00 129.00
Income/Loss From Continuing Operations Before Tax
160.91%
-148.00
243.00 229.00 101.00 129.00
Income Tax Expense/Benefit, Deferred
25.00%
30.00
40.00 10.00 -17.00 10.00
Income Tax Expense/Benefit
31.33%
57.00
83.00 84.00 14.00 20.00
Income/Loss From Continuing Operations After Tax
228.12%
-205.00
160.00 145.00 87.00 109.00
Net Income/Loss
228.12%
-205.00
160.00 145.00 87.00 109.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.91%
0.229
259.98 259.94 257.86 0.216
Diluted Average Shares
99.94%
0.153
260.65 260.16 261.00 0.244
Basic Earnings Per Share
229.51%
-0.79
0.61 0.56 0.34 0.42
Diluted Earnings Per Share
227.87%
-0.78
0.61 0.56 0.33 0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general PFE
$26.58
price down icon 1.04%
drug_manufacturers_general NVO
$37.96
price down icon 0.16%
$144.99
price down icon 0.15%
$366.21
price down icon 0.43%
drug_manufacturers_general MRK
$115.61
price down icon 0.26%
drug_manufacturers_general NVS
$153.44
price down icon 0.53%
Kapitalisierung:     |  Volumen (24h):